Healthcare Market Research Reports and Trends

According to the new market research report  “ Metagenomic Sequencing Market by Workflow (Sample Preparation, Data Analysis), Product & Services (Reagents, Consumables, Instruments), Technology (Shotgun, 16s Rrna, Whole-Genome), Application (Diagnostic, Soil Microbiome) – Global Forecast to 2024″ , published by MarketsandMarkets™, the Metagenomic Sequencing Market is projected to reach USD 2.3 billion by 2024 from USD 1.0 billion in 2019 at a CAGR of 17.0%. Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=60408643 The growth of this market is driven by factors such as the significant applications of metagenomics in various fields, the various initiatives and funding from government & private bodies for large-scale sequencing projects, and the declining cost of sequencing. The availability of cloud computing for data management is another factor providing market players with growth opportunities. Reagents & consumables accounted for th

Growing prevalence and incidence of various disorders such as obesity and CVDs, increasing incidence of trauma, growth in the number of accidents, rising need to manage blood loss in patients, growth in the number of surgeries, and rising geriatric population. How is Growth of Surgical Sealants and Adhesives Market? The  global surgical sealants and adhesives market  is estimated to grow at a  CAGR  of 9.6% from 2016 to 2021 to reach $2.96 Billion by 2021.  In addition, the greater uptake of technologically advanced products and growing adoption of surgical sealants and adhesives in the U.S. and Europe (owing to FDA and CE Mark approvals) are responsible for driving the overall growth of this market. What Report Covers of Surgical Sealants and Adhesives Market? the surgical sealants market is segmented on the basis of product, indication, application, and region. On the basis of product, the market is segmented into natural/biological sealants and adhesives and synthetic &

Increasing incidences of peripheral vascular diseases, liver cancer, strokes, and uterine fibroids coupled with rising preference for minimally invasive procedures; increasing investments, funds, and grants by public-private organizations for research; and technological advancements in the market will fuel the market growth Growth in Embolotherapy Market The  global embolotherapy market  is projected to reach $4.9 billion by 2024 from $3.3 billion in 2019, at a  CAGR of 8.1% from 2019 to 2024. The growth of the embolotherapy market is mainly attributed to factors such as the growth in the target patient population, rising preference for minimally invasive procedures, technological advancements in embolotherapy devices, and favorable reimbursement scenario. Product of Embolotherapy Market Market is broadly segmented into embolic agents and support devices. The embolic agents segment is further subsegmented into embolic coils, embolic plug systems, liquid embolic agents, mi

The growth in this market is driven by the rising companion animal population, increasing demand for pet insurance, and the growth in the number of veterinary practitioners in developed countries. The growing demand for rapid tests and portable instruments for point-of-care services is expected to offer potential growth opportunities for market players in the coming years. Growth in Companion Animal Diagnostics Market The  global companion animal diagnostics market  is projected to reach $2.7 billion by 2024 from $1.7 billion in 2019, at a  CAGR  of 9.8%. Technology  –  Companion Animal Diagnostics Based on technology, the companion animal diagnostics market is segmented into clinical biochemistry, immunodiagnostics, hematology, urinalysis, molecular diagnostics, and other companion animal diagnostic technologies. The clinical biochemistry segment is expected to grow at the highest CAGR during the forecast period. The higher preference for various advanced clinical di

Factors contributing to the growth of this market include the rising incidence and prevalence of chronic and infectious diseases, growing funding for cancer research, growing cell-based research, and development of apoptosis-modulating drugs. Growth in Global Apoptosis Assays Market The  global apoptosis assays market  is projected to reach $5.9 billion by 2023 from $3.6 billion in 2018, at a  CAGR  of 10.5%. The cell imaging & microscopy segment is expected to grow at the highest CAGR during the forecast period Based on detection technology, the cell imaging and microscopy is expected to grow at the fastest growth rate during the forecast period. The cell imaging and microscopy segment is expected to witness the highest CAGR due to its increasing adoption of cell imaging and microscopy in diagnostic laboratories, drug discovery applications, and basic research. Download PDF Brochure Assay kits segment to witness the highest growth during the forecast period On

Increasing number of neurological disorders, increasing incidence of hearing loss, increasing prevalence of diabetes, and increasing cases of amputation due to the rising number of accidents & injuries are contributing to the growth of this market. Growth of Neuroprosthetics Market The  global neuroprosthetics market  was valued at $5.28 Billion in 2016 and expected to grow at a  CAGR  of 12.4%, to reach $10.48 Billion in 2022. Neuroprostheses uses electrodes to interface with the central or peripheral nervous system to restore lost motor or sensory capabilities. These devices can receive neural signals from the external environment & brain, and convert the signals to restore functions such as loss of hearing and vision. They have applications in cognitive disorders, ophthalmic disorders, motor disorders, and auditory disorders. Request for Sample Pages Segment The neuroprosthetics market is segmented on the basis of type, technique, and application. The physi

According to the new market research report  “Contrast Media Injectors Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Heads, Syringes), Accessories), Application (Radiology, Interventional Cardiology), & End Users (Hospitals) – Global Forecast to 2024” , published by MarketsandMarkets™, the global Contrast Media Injectors Market is projected to reach USD 1.8 billion by 2024 from USD 1.3 billion in 2019, at a CAGR of 6.1% during the forecast period. Factors such as the growing prevalence of cancer and CVD; a large number of approvals for contrast agents; and increasing investments, funds, and grants by government organizations are driving the growth of the Contrast Media Injectors Market. However, the high cost of contrast media injectors and consumables & accessories is restraining the growth of the market to a certain extent. Download PDF Brochure The consumables segment accounted for the largest share of the contrast media injec

Factors such as the growing worldwide prevalence of HIV/AIDS, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments and kits, and increasing government initiatives are expected to drive the growth of the market worldwide. AIDS is a major public health concern with a prevalence rate that has increased dramatically in the past two decades. This increase in the prevalence of HIV, and the subsequent increase in the number of patients suffering from AIDS, has resulted in an increase in the demand for advanced technologies for HIV diagnostics . According to the World Health Organization (WHO), in 2016, around 36 million people were diagnosed with HIV globally, of which 2.1 million were reported to be cases of new HIV infections. Globally, 1.1 million people died from HIV-related causes in 2015. According to the CDC, in 2015, more than 1.2 million people in the U.S. were reportedly infected with HIV, and almost 19% of these were

A companion diagnostic assay is an in vitro diagnostic device (IVD) that is used to identify whether a patient with certain diseases could be benefitted by a particular drug through the biomarker assessment. The key factors driving the growth of this market include the increasing lung cancer cases, growing number of genetic testing, rising need for personalized medicines, and regulatory guidelines that support the  companion diagnostics market . The  global companion diagnostics market  is projected to reach USD 7.3 billion by 2024 from USD 3.5 billion in 2019, at a  CAGR  of 15.7%. Market Dynamics – Drivers Advantages of Companion Diagnostics Growing Need for Targeted therapy Growing Importance of Personalized Medicine Increasing Global Incidence of Cancer Growing Application Areas of Companion Diagnostics Polymerase chain reaction (PCR) segment to account for the largest share of the companion diagnostics market, by technology, in 2019 The extractables/leachables

Growth in the fetal and  Neonatal care equipment market  is mainly driven by the rise in number of preterm and low-weights birth infants, growing number of NICU admissions, and increased awareness of neonatal and fetal care across developing nations. Growth in the in fetal dopplers segment can be attributed to factors such as the growing demand for digital Dopplers over conventional Dopplers and increasing launches of home-use products. The growing popularity of and demand for fetal Doppler devices is increasing due to the procedural advantages these devices offer, such as ease of use, mobility (handheld and battery-operated products), novel features, and display functionalities.  The rising adoption of Doppler imaging (especially in first trimester of pregnancy and for the diagnosis of restricted fetal growth), growing preference for the assessment of the fetal-placental circulatory system, expansion of application horizon for fetal Doppler imaging (such as in aneuploidy scr